Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis.

Neurobiology of Aging
Yevgeniya AbramzonBryan J Traynor

Abstract

We recently reported that mutations in the valosin-containing protein (VCP) gene are a cause of 1%-2% of familial amyotrophic lateral sclerosis (ALS) cases, but their role in the pathogenesis of sporadic ALS is unclear. We undertook mutational screening of VCP in 701 sporadic ALS cases. Three pathogenic variants (p.Arg159Cys, p.Asn387Thr, and p.R662C) were found in three U.S. cases, each of whom presented with progressive upper and lower motor neuron signs consistent with definite ALS by El Escorial diagnostic criteria. Our data indicate that VCP mutations may underlie apparently sporadic ALS but account for <1% of this form of disease.

References

Apr 17, 2002·Science·Howard M CannL Luca Cavalli-Sforza
Oct 29, 2002·Annals of Neurology·Michael D AlexanderOrla Hardiman
Sep 25, 2007·Neurobiology of Aging·Anna BersanoStefania Corti
Feb 13, 2008·Neurology·A ChiòG Restagno
May 20, 2009·Neurobiology of Aging·Adriano ChiòUNKNOWN ITALSGEN Consortium
Feb 9, 2010·Neurobiology of Aging·Shiao-Lin LaiBryan J Traynor
Mar 17, 2010·Human Mutation·Mariely DeJesus-HernandezRosa Rademakers
Jul 6, 2010·Neurobiology of Aging·Adriano ChiòGabriella Restagno
Sep 25, 2010·Lancet Neurology·Ian Ra MackenzieManuela Neumann
Dec 15, 2010·Neuron·Janel O JohnsonBryan J Traynor

❮ Previous
Next ❯

Citations

Jul 28, 2012·Alzheimer's Research & Therapy·Jennifer C Schymick, Bryan J Traynor
Nov 16, 2012·Neurology·Paloma González-PérezSergiu C Blumen
Jan 21, 2014·Antioxidants & Redox Signaling·Chris McKinnon, Sarah J Tabrizi
Aug 16, 2014·Brain : a Journal of Neurology·Michael A GonzalezMichael E Shy
Jul 3, 2015·Protein Science : a Publication of the Protein Society·Dominik BarthelmeRobert T Sauer
Oct 30, 2015·Rinshō shinkeigaku = Clinical neurology·Mari SegawaYoshikazu Ugawa
Dec 15, 2015·Environmental Health and Preventive Medicine·Akio KoizumiShohab Youssefian
Nov 27, 2015·Journal of Molecular Biology·Dominik Barthelme, Robert T Sauer
Jan 6, 2015·Annals of the New York Academy of Sciences·Adeline S L NgBruce L Miller
Jan 19, 2016·Brain Pathology·Mario SabatelliSerena Lattante
Aug 19, 2015·Neurobiology of Disease·Giovanni Manfredi, Hibiki Kawamata
Dec 17, 2014·Neurobiology of Aging·Bradley N SmithChristopher E Shaw
Mar 6, 2013·Biochimica Et Biophysica Acta·Philippe Cloutier, Benoit Coulombe
Jan 27, 2015·Journal of the Neurological Sciences·Chun Tak KwokJackie de Belleroche
Apr 16, 2013·Biochimica Et Biophysica Acta·André FranzThorsten Hoppe
Jan 27, 2015·Neuromuscular Disorders : NMD·Conrad C WeihlMatthew B Harms
May 29, 2016·Progress in Neurobiology·Mónica ZufiríaAdolfo López de Munain
Jun 18, 2016·Neuromuscular Disorders : NMD·Teresinha EvangelistaUNKNOWN VCP related diseases Consortium
Oct 25, 2016·Neurobiology of Aging·Qiang GangUNKNOWN Muscle Study Group and The International IBM Genetics Consortium
Dec 7, 2016·Continuum : Lifelong Learning in Neurology·Zachary Simmons
Jan 4, 2017·Human Molecular Genetics·Daniel FilMahmoud Kiaei
Mar 9, 2017·Cold Spring Harbor Perspectives in Medicine·Mehdi Ghasemi, Robert H Brown
May 5, 2020·Annals of Clinical and Translational Neurology·Ana T MarcosPedro A Lazo
Apr 7, 2020·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Ilaria MartinelliJessica Mandrioli
May 26, 2016·Journal of Clinical Neuromuscular Disease·Mohamed KazamelMargherita Milone
Dec 19, 2016·Frontiers in Molecular Biosciences·Wai Kwan Tang, Di Xia
Jul 1, 2017·Frontiers in Molecular Biosciences·Yihong YeDi Xia
Feb 20, 2018·The Journal of Clinical Investigation·YouJin LeeBjarne Udd
Aug 11, 2020·Journal of Neuromuscular Diseases·Jens Reimann, Cornelia Kornblum
Nov 12, 2015·Frontiers in Cellular Neuroscience·Anaïs Aulas, Christine Vande Velde
Jan 9, 2021·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Tomoyasu MatsubaraShigeo Murayama
Jan 23, 2021·Nature Communications·Alyssa E JohnsonGraeme W Davis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.